Montelair Chewable tablets and Film-coated tablets.

Clonmel Healthcare is delighted to announce the launch of Montelair (Montelukast) 4mg , 5mg Chewable tablets and 10mg Film-coated tablets.

Montelair2


Montelair (Montelukast) 10mg Film-coated Tablets are indicated for:

  • The treatment of asthma as add-on therapy in those patients, 15 years and older, with mild to moderate persistent asthma who are inadequately controlled on inhaled corticosteroids and in whom ‘as-needed’ short-acting beta-agonists provide inadequate clinical control of asthma
  • Adult asthmatic patients (15 years and over) in whom Montelair is indicated in asthma, Montelair can also provide symptomatic relief of seasonal allergic rhinitis.
  • The prophylaxis of asthma in patients in which the predominant component is exercise-induced bronchoconstriction.

Also available, Montelair 4mg Chewable tablets for patients aged 2 to 5 years and Montelair 5mg Chewable tablets for patients aged 6 to 14 years.

Please refer to the summary of product characteristics for full details of indications.

Montelair Chewable and Film-coated tablets are available in a 28 pack.

Full prescribing information for Montelair is available on request or go to www.clonmel-health.ie .

This Product is subject to medical prescription. Montelair is GMS reimbursable from 1st March 2013.

Please contact Clonmel Healthcare on 01-6204000 if you require any additional information on Montelair

Montelair